Search for: "BIO CLINICAL DEVELOPMENT, INC."
Results 1 - 20
of 56
Sorted by Relevance
|
Sort by Date
8 Aug 2018, 9:08 am
The post National Securities Corp Broker Jonathan Aschoff Recommended Avenue Therapeutics (ATXI.O), Checkpoint Therapeutics (CKPT.O) Inc., and Mustang Bio Inc. [read post]
2 Jun 2021, 2:55 pm
Some background: The asserted patents arise out of research conducted by inventors at a company called QuantaLife, Inc. [read post]
22 May 2013, 7:43 pm
Radius intends to use the funding to support its clinical development programs for BA058, the company's anabolic, bone-building compound developed for the treatment of patients with osteoporosis at high risk of fracture. [read post]
22 May 2013, 7:43 pm
Radius intends to use the funding to support its clinical development programs for BA058, the company's anabolic, bone-building compound developed for the treatment of patients with osteoporosis at high risk of fracture. [read post]
17 Jun 2012, 3:52 pm
The focus of their audience is management level decision makers, such as the c-suite and director level, providing information regarding pre-clinical drug discovery and development up to commercialization. [read post]
25 Jul 2010, 5:00 am
Department of Defense for the investigation of brain injury bio markers. [read post]
10 Jan 2013, 7:54 am
In September 2012, iBio and GE Healthcare announced the formation of a new global alliance, and iBio’s technology is being used for development of a new recombinant yellow fever vaccine under a commercial license and product development collaboration with Fiocruz/Bio-Manguinhos. [read post]
9 Jan 2020, 12:29 pm
The research and development process for pharma companies often involves costly and lengthy clinical testing trials that yield specific data. [read post]
11 Jul 2013, 1:03 pm
All on top of the news in June when bluebird bio of Masschusetts brought in $101 million on its stock offering. [read post]
30 Jan 2016, 12:28 pm
While investments in big name pharmaceuticals with diversified portfolios of established drugs and products offer greater stability some brokers recommend small bio-technology companies that have only one or two unproven drugs in clinical trials or development. [read post]
29 Sep 2017, 12:26 pm
Most small pharmaceutical companies have limited business operations other than research and development of a handful of drugs. [read post]
11 Jan 2016, 8:03 am
It also provides hazardous waste management, clinical services, medical compliance and waste programs, pharmaceutical waste disposal, Bio Systems reusable sharps containers, integrated waste stream solutions and medical safety products. [read post]
11 Jan 2016, 8:03 am
It also provides hazardous waste management, clinical services, medical compliance and waste programs, pharmaceutical waste disposal, Bio Systems reusable sharps containers, integrated waste stream solutions and medical safety products. [read post]
3 Apr 2018, 7:30 am
Word Mark Click To View 5434926 FINISH LINE TSDR 5435259 THE GREAT RELATIONSHIP ACADEMY TSDR 5433328 VIETNUMMY TSDR 5433288 FIRE N THE HOLE TSDR 5433197 BIO-ARCH TSDR 5433180 FAST FOOD FOR HEALTHY PEOPLE TSDR 5433169 CLASSYCURLIES TSDR 5432416 BEEFREE TSDR 5432238 EMPOWERING GREAT MISSIONS TSDR 5432237 POWERFUL FUNDRAISING SOLUTIONS TSDR 5432213 INFINITY LANDSCAPE INC. [read post]
19 Jul 2022, 2:59 pm
There is typically one corrective disclosure—a negative clinical-trial or other FDA-approval development—so under loss-causation law, they can only be about that one thing. [read post]
28 Nov 2009, 4:23 pm
Here is news of pharamaceutical developments on the MJ front: Cannabis Science Inc. [read post]
20 Dec 2007, 3:00 am
Short speker bios are at the end. [read post]
10 Oct 2008, 3:22 pm
The jointly developed stent has performed well in clinical trials. [read post]
16 Feb 2012, 5:56 pm
FDA-2004-P-0214) by the Biotechnology Industry Organization (“BIO”) and Genentech, Inc. [read post]
11 Mar 2009, 5:19 pm
Biotechnology Industry Organization (BIO): New Proposed Biosimilars Pathway Filled With Potholes: The Biotechnology Industry Organization (BIO) continues to support strongly the development of a pathway for the review and approval of biosimilars. [read post]
